Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 7610751!ä!7610751 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Acta+Chir+Belg 1995 ; 95 (3): 162-5 Nephropedia Template TP {{tp|p=7610751|t=1995. Piperacillin-tazobactam treatment for severe intra-abdominal infections |pdf=|usr=}}{{7610751}} gab.com Text Piperacillin-tazobactam treatment for severe intra-abdominal infections JO: Acta Chir Belg http://www.kidney.de/pget.php?&tw=1&pmid=7610751 #FOAvip In this limited series of 23 patients suffering from severe or life-threatening intra-abdominal infection, piperacillin + tazobactam, together with adequate surgical drainage and resections, cured 78% of our patients and eradicated almost all the pathogens. Side effects included essentially eosinophilia and elevation of transaminases but was never severe. Piperacillin + tazobactam seem thus to be an acceptable treatment, associated with correct surgical drainage. This regimen has to be compared in appropriate trial versus gold standard therapy, such as imipenem, a beta-lactam with aminoglucoside and imidazole or clindamycin or with broad spectrum beta-lactam and other inhibitors or beta-lactamases, but our rate of cure is impressive in such a population. Twit Text FOAVip Piperacillin-tazobactam treatment for severe intra-abdominal infections ????Acta Chir Belg http://www.kidney.de/pget.php?&tw=1&pmid=7610751 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=7610751 #FOAvip English Wikipedia <ref>{{Cite pmid|7610751}}</ref> Piperacillin-tazobactam treatment for severe intra-abdominal infections #MMPMID7610751 Legrand JC; Bastin F; Belva P; Chastel C; Renaux J; Van Eukem P Acta Chir Belg 1995[May]; 95 (3): 162-5 PMID7610751show ga In this limited series of 23 patients suffering from severe or life-threatening intra-abdominal infection, piperacillin + tazobactam, together with adequate surgical drainage and resections, cured 78% of our patients and eradicated almost all the pathogens. Side effects included essentially eosinophilia and elevation of transaminases but was never severe. Piperacillin + tazobactam seem thus to be an acceptable treatment, associated with correct surgical drainage. This regimen has to be compared in appropriate trial versus gold standard therapy, such as imipenem, a beta-lactam with aminoglucoside and imidazole or clindamycin or with broad spectrum beta-lactam and other inhibitors or beta-lactamases, but our rate of cure is impressive in such a population. |Abdomen/surgery[MESH] |Adult[MESH] |Aged[MESH] |Drainage[MESH] |Drug Therapy, Combination/*therapeutic use[MESH] |Eosinophilia/chemically induced[MESH] |Female[MESH] |Gram-Negative Bacterial Infections/*drug therapy/surgery[MESH] |Gram-Positive Bacterial Infections/*drug therapy/surgery[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Penicillanic Acid/administration & dosage/adverse effects/*analogs & derivatives[MESH] |Piperacillin/*administration & dosage/adverse effects[MESH] |Tazobactam[MESH]Piperacillin-tazobactam treatment for severe intra-abdominal infection(epmc).pdf DeepDyve Pubget Overpricing